New Delhi, Feb. 10 -- French drug innovator Servier is partnering with domestic players to develop, manufacture and export formulations for the global market, highlighting India's growing role in global R&D.

The mid-sized pharmaceutical company said it aims to marry Indian expertise in chemical formulations and 'incremental innovation' with its discovery prowess to speed up drug development and manufacturing for its global markets.

While Servier, the second largest French drugmaker, has been manufacturing locally in partnership with contract manufacturers for the Indian market, the company announced a €15 million investment to set up a platform called Gatinn to develop single-pill combinations for cardiometabolic and venous diseas...